Company Financials

Taro Pharmaceutical Industries Ltd. Financials

United States dollar

business Taro Pharmaceutical Industries Ltd. Company Profile

Main Stock Listing

NYSE: TARO

Market Capitalization $1.62 Billion as of June 1, 2024

Market Cap History

Valuations Metrics as of May. 5, 2024

Trailing PE 34.75
Forward PE 9.66
Price to Sales TTM $2.61
Price to Book MRQ $0.90
Enterprise to Revenue 1.13
Enterprise to EBITDA 10.04

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends 2023-03-31
Most Recent Quarter 2023-12-31
Profit Margin 7.48%
Operating Margin 10.70%
Return on Assets TTM 1.03%
Return on Equity TTM 2.61%

Income Statement

Revenue TTM $610,828,032
Revenue per Share TTM $16.25
Quarterly Revenue Growth 12.90%
Gross Profit TTM $268,323,000
EBITDA $74,406,000
Net Income to Common TTM $45,702,000
Diluted EPS TTM $1.22
Quarterly Earnings Growth YoY 178.20%

Balance Sheet

Total Cash MRQ $902,216,000
Total Cash per Share MRQ $24.01
Total Debt MRQ $
Total Debt to Equity MRQ 0.00
Current Ratio MRQ 3.60
Book Value per Share MRQ $47.34

Cash Flow

Operating Cash Flow TTM $142,868,000
Levered Free Cash Flow TTM $81,011,624

TARO Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding 37,584,600
Float Shares 8,085,638
Avg 10 Volume 21,520
Avg 30 Volume None
Shares Short 47,181
Short Ratio 1.48
Short % of Shares 0.58%
% Held by Insiders 78.48%
% Held by Institutions 13.42%

Stock Price Summary

Beta 0.61
Fifty Two Week Low $27.37
Fifty Two Week High $45.76
Fifty Two Week Change 31.80%
Day 50 MA $42.13
Day 200 MA $39.21

Dividends and Splits

Forward Annual Dividend Rate $51.24
Forward Annual Dividend Yield 120.71%
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date 2018-12-28
Ex Dividend Date 2018-12-10
Last Split Factor
Last Split Date 2001-07-27